Login to Your Account

Roche Paying Isotechnika Up To $215M For Transplantation Drug

By Kim Coghill

Wednesday, April 10, 2002
Hoffmann-La Roche Inc. agreed to spend upward of $215 million in a global partnership with Isotechnika Inc. to develop a transplantation drug with blockbuster potential. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription